Effects of curcumin on cyclosporine-induced cholestasis and hypercholesterolemia and on cyclosporine metabolism in the rat

Planta Medica

Volumn 69, Issue 4, 2003, Pages 337-343

  Deters, Michael ^a   Klabunde, Til ^a   Meyer, Hartmut ^b   Resch, Klaus ^a   Kaever, Volkhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

Cholestasis; Curcuma spec.; Curcumin; Cyclosporine; Hypercholesterolemia; Zingiberaceae

Indexed keywords

BILE SALT; BILIRUBIN; CHOLESTEROL; CURCUMA LONGA EXTRACT; CURCUMIN; CYCLOSPORIN; CYCLOSPORIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT FISTULA; BILE FLOW; BILIARY EXCRETION; CHOLESTASIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG METABOLISM; DRUG STRUCTURE; DRUG TISSUE LEVEL; HYPERCHOLESTEROLEMIA; MALE; NONHUMAN; RAT; STRUCTURE ANALYSIS; ZINGIBERACEAE;

ADMINISTRATION, ORAL; ANIMALS; ANTILIPEMIC AGENTS; BILE; BILE ACIDS AND SALTS; BILIARY FISTULA; CHOLAGOGUES AND CHOLERETICS; CHOLESTASIS; CHOLESTEROL; CURCUMA; CURCUMIN; CYCLOSPORINE; DISEASE MODELS, ANIMAL; HYPERCHOLESTEROLEMIA; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAPERITONEAL; MALE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; TRIGLYCERIDES;

ANIMALIA; CURCUMA; CURCUMA LONGA; RATTUS NORVEGICUS; ZINGIBERACEAE;

EID: 0038629458     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38870     Document Type: Article

References (23)

1. Burke JF, Pirsch JD, Ramos EL, Salomon DR, Stablein DM, Van Buren DH, West JC. Long-term efficacy and safety of cyclosporine in renal-transplant recipients. N Engl J Med 1994; 331: 358-63
2. Lorber MI, Van Buren CT, Lechner SM, Williams C, Kahan BD. Hepatobiliary and pancreatic complications of cyclosporine therapy in 466 renal transplant recipients. Transplantation 1987; 43: 35-40
3. Deters M, Strubelt O, Younes M. Reevaluation of cyclosporine induced hepatotoxicity in the isolated perfused rat liver. Toxicology 1997; 123: 197-206
4. Groth CG, Backman L, Morales JM, Calne R, Kreis H, Lang P, Touraine JL, Claesson K, Campistol JM, Durand D, Wramner L, Brattstrom C, Charpentier B. Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group. Transplantation 1999; 67: 1036-42
5. Deters M, Siegers C, Muhl P, Hansel W. Choleretic effects of curcuminoids on an acute cyclosporin-induced cholestasis in the rat. Planta Med 1999; 65: 610-3
6. Deters M, Siegers C, Hansel W, Schneider KP, Hennighausen G. Influence of curcumin on cyclosporin-induced reduction of biliary bilirubin and cholesterol excretion and on biliary excretion of cyclosporin and its metabolites. Planta Med 2000; 66: 429-34
7. Soni KB, Kuttan K. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol 1992; 36: 273-5
8. Ranjan D, Johnston TD, Wu G, Elliott L, Bondada S, Nagabushan M. Curcumin blocks cyclosporine A-resistant CD28 costimulatory pathway of human T-cell proliferation. J Surg Res 1998; 77: 174-8
9. Deters M, Klabunde T, Kirchner G, Resch K, Kaever V. Sirolimus/cyclosporine/tacrolimus interactions on bile flow and biliary excretion of immunosuppressants in a subchronic bile fistula rat model. B J Pharmacol 2002; 136: 604-12
10. Christians U, Zimmer KO, Wonigeit K, Maurer G, Sewing KF. Liquid chromatographic measurement of cyclosporine A and its metabolites in blood, bile and urine. Clin Chem 1988; 34: 34-9
11. CONSENSUS DOCUMENT. Hawk's Cay meeting on the therapeutic drug monitoring of cyclosporine. Transplant Proc. 1999; 22: 1357-61
12. Moseley RH, Johnson TR, Morrissette JM. Inhibition of bile acid transport by cyclosporine A in rat liver plasma membrane vesicles. J Pharmacol Exp Ther 1990; 253: 974-80
13. Meier PJ, Stieger B. Bile salt transporters. Annu Rev Physiol 2002; 64: 635-61
14. Stacey NH, Kotecka B. Inhibition of taurocholate and ouabain transport in isolated rat hepatocytes by cyclosporin A. Gastroenterology 1988; 95: 780-6
15. Böhme M, Müller M, Leier I, Jedlitschky G, Keppler D. Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver. Gastroenterology 1994; 107: 255-65
16. Paulusma CC, van Geer MA, Evers R, Heijn M, Ottenhoff R, Borst P, Oude Elferink RP. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J 1999; 338: 393-401
17. Moran D, De Buitrago JM, Fernandez SM, Galan AI, Munoz ME, Jimenez R. Inhibition of biliary glutathione secretion by cyclosporine A in the rat: possible mechanisms and role in the cholestasis induced by the drug. J Hepatol 1998; 29: 68-77
18. Graham J, Ahmed H, Northfield TC. Unidirectional pathway of vesicular cholesterol transport.. In: Trends in Bile Salt Research. Paumgartner G, Dordrecht, editors. New York: Kluwer, 1989: pp. 177-87
19. Galan AI, Fernandez SM, Moran D, Munoz ME, Jimenez R. Cyclosporine A hepatotoxicity: effect of prolonged treatment with cyclosporine on biliary lipid secretion in the rat. Clin Exp Pharmacol Physiol 1995; 22: 260-5
20. Li D, Zimmerman TL, Thevananther S, Lee HY, Kurie JM, Karpen SJ. Interleukin-1beta-mediated suppression of RXR:RAR transactivation of the Ntcp promoter is JNK-dependent. J Biol Chem 2002; 277: 31416-22
21. Romiti N, Tongiani R, Cervelli F, Chieli E. Effects of curcumin on P-glycoprotein in primary cultures of rat hepatocytes. Life Sci 1998; 62: 2349-58
22. Sambaiah K, Srinivasan K. Influence of spices and spice principles on hepatic mixed function oxygenase system in rats. Indian J Biochem Biophys 1989; 26: 254-8
23. Oetari S, Sudibyo M, Commandeur JN, Samhoedi R, Vermeulen NP. Effects of curumin on cytochrome P450 and glutathione S-transferase activities in rat liver. Biochem Pharmacol 1996; 51: 39-45